Clinical Trials and Research at the Penn Brain Tumor Center

Clinical Trials and Research at the Penn Brain Tumor Center

Through its partnership with the Abramson Cancer Center, the Penn Brain Tumor Center offers access to innovative advances in treatment -- including immunotherapy -- through personalized clinical trials.

The twofold object of these trials is to extend patient survival beyond its current average, and to generate a database of critical information for neurosurgeons and oncologists worldwide.

Among other accomplishments, the Penn Brain Tumor Center has the leading CAR-T for glioblastoma clinical research program in the nation.

Providers, if you think your patient may be a candidate for neurosurgery at Penn Medicine, consult on our provider-only line: 877-937-PENN (7366)

 

Related links:

Weekly Tumor Board Meetings at the Penn Brain Tumor Center
The Brain Tumor Center | Improving Outcomes for Brain Tumor Patients
Brain Tumor Center
Glioblastoma Immunotherapy Research at Penn Medicine, Including CART-EGFRvIII Therapy
Follow clinical updates from Penn on Twitter


Published

October 8, 2019

Created by

Penn Physician VideoLink